EFDID: 323381EFD: View Filing

Issuer: Amalgam Rx, Inc. (0001667234) - D

Accession: 0001667234-19-000004 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001667234
  • Entity Name:
    Amalgam Rx, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2016)
  • Address:
    1007 N. MARKET STREET
    SUITE 400
    WILMINGTON, DE 19801
  • Persons:
    Related Persons 2
    Ryan A Sysko
    Executive Officer, Director
    Sarwar Islam
    Director
EDGAR: Offering Information
  • Accession Date:
    10/08/2019
  • First Sale Date:
    09/23/2019
  • Offering Amount:
    $750,000
  • Amount Sold:
    $650,000
  • Amount Remaining:
    $100,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Debt
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:MD, NJ, PA
EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Amalgam Rx, Inc.Ryan A. SyskoRyan A. SyskoPresident and CEO2019-10-07